Skip to main content
Caplight Logo









Mycelial

Mycelial

Private
New York City, New YorkAI, Data & Cloud Infrastructurehttps://mycelial.com/

Last Round

Seed

Nov 8, 2021

Total Funding Raised

$3.8M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Mycelial operates in AI, Data & Cloud Infrastructure and is based in New York City, New York. Its latest recorded funding round was a Seed round in November 2021.

Mycelial is a software company that provides a point-to-point ETL (Extract, Transform, Load) platform designed to synchronize data between databases and applications at the edge without requiring central cloud transit.

Sector

AI, Data & Cloud Infrastructure

Verticals

Edge Computing, Data Integration, Database Management

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mycelial Comparables

Compare Mycelial with similar companies based on industry and business-model similarity.

Mycelial comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ditto
82%
Supabase
78%
ElectricSQL
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mycelial Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 8, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mycelial Investors

Notable investors and investment history

Mycelial investors
InvestorRounds
Crane Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 127% MoM, reaching 4.4K.

  • Jul 26, 2026

    Monthly visitors grew 151% MoM, reaching 1.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Mycelial Filings

Explore SEC and related filing metadata, where available.

Mycelial filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mycelial's valuation, stock price, and market status.

Is Mycelial a public or private company?

Mycelial is a private company.

What is the current stock price of Mycelial?

Mycelial is a private company, so its shares have no public market price. Caplight tracks Mycelial's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mycelial worth (valuation)?

Valuation information for Mycelial is not publicly available.

Can I buy Mycelial stock?

Mycelial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mycelial's last funding round?

Mycelial's most recent funding round was Seed on November 8, 2021.

Who are the main investors in Mycelial?

Key investors in Mycelial include Crane Venture Partners.

Will Mycelial IPO soon?

No public IPO plans have been announced for Mycelial.

How can I track Mycelial secondary market activity?

Caplight tracks bids, offers, and trades in Mycelial's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range1
Year Founded2021
Last FundingNov 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?